Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases (Q28144740)

2

0 references

S M Hassan

3

0 references

R Kumar

4

0 references

S Narain

5

0 references

A Kumar

6

0 references

language of work or name

English

0 references

publication date

1999

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

PubMed

published in

0 references

volume

93

0 references

issue

3

0 references

page(s)

319-23

0 references

cites work

An in Vitro Model for Investigation of Chemotherapeutic Agents in Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990037-8

7 January 2021

How do the polyene macrolide antibiotics affect the cellular membrane properties?

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990037-8

7 January 2021

In vitro tumor necrosis factor induction assay for analysis of febrile toxicity associated with amphotericin B preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990037-8

7 January 2021

Leishmania infantum: lack of parasite resistance to amphotericin B in a clinically resistant visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990037-8

7 January 2021

Induction of prostaglandin synthesis as the mechanism responsible for the chills and fever produced by infusing amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990037-8

7 January 2021

Leishmania spp.: development of pentostam-resistant clones in vitro by discontinuous drug exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990037-8

7 January 2021

Evaluation of diamidine compound (pentamidine isethionate) in the treatment resistant cases of kala-azar occurring in North Bihar, India

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990037-8

7 January 2021

Use of amphotericin B in drug-resistant cases of visceral leishmaniasis in north Bihar, India.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990037-8

7 January 2021

Cardiopulmonary toxicity after liposomal amphotericin B infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990037-8

7 January 2021

Amphotericin versus pentamidine in antimony-unresponsive kala-azar

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990037-8

7 January 2021

A comparison of intercostal and abdominal routes of splenic aspiration and bone marrow aspiration in the diagnosis of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990037-8

7 January 2021

Sodium antimony gluconate, amphotericin, and myocardial damage

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990037-8

7 January 2021

Comparison of Regimes of Treatment of Antimony-Resistant Kala-Azar Patients: A Randomized Study

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990037-8

7 January 2021

Are incremental doses of amphotericin B required for the treatment of visceral leishmaniasis?

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990037-8

7 January 2021

Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990037-8

7 January 2021

Amphotericin B: an introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990037-8

7 January 2021